Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.